Laibo Cosmeceuticals Debuts at COSMETIC 360 in France: A Chinese Technological Dialogue on "Skin Self-Healing"

When Eastern wisdom meets Parisian romance, the code of skin regeneration is being rewritten. At 10:25 AM on October 15, 2026, R&D representatives from Laibo Cosmeceuticals appeared at the 12th French COSMETIC 360 International Innovation Fair, delivering a technical presentation titled "Biomimetic Liquid Crystal Emulsification Technology for Skin Barrier Regeneration in Mild Atopic Dermatitis" at the Carrousel du Louvre in Paris.

As a premier global stage for cosmetics innovation, COSMETIC 360 annually gathers ingredient suppliers, brands, and scientific research institutions from around the world at the Louvre. With this edition themed "REGENERATIONS," Laibo Cosmeceuticals was successfully shortlisted thanks to its original technologies in the field of skin barrier regeneration, becoming one of the Chinese tech enterprises to take the stage at this international event.

Swipe left and right to view the live photo gallery

Atopic dermatitis (AD) is a chronic inflammatory skin condition affecting a vast number of patients worldwide, with individuals suffering from mild AD facing prolonged struggles with barrier damage and recurring itching. The core of Laibo Cosmeceuticals' presentation—Biomimetic Liquid Crystal Emulsification Technology—was developed precisely to address this unmet need.

The inspiration for this technology stems from the lamellar lipid structure of a healthy stratum corneum. Through an O/LC/W (oil/liquid crystal/water) biomimetic liquid crystal system, the R&D team constructed a lamellar liquid crystal film on the skin surface resembling the natural stratum corneum, forming an exogenous physical barrier. It not only boosts the stratum corneum hydration levels, but also reduces transepidermal water loss (TEWL) via a continuous lipid film, building the first line of defense for fragile skin barriers.

However, Laibo's breakthrough goes far beyond merely "repairing the surface." After screening over a hundred types of polysaccharides, the team discovered that low-molecular-weight oat β-glucan can dose-dependently upregulate the expression of FLG and Caspase-14, activating endogenous skin hydration pathways. In this way, the exogenous liquid crystal film provides immediate protection while the endogenous pathways deliver long-lasting repair—working synergistically through dual pathways to truly bridge the gap from "soothing" to "regeneration."

In a randomized controlled trial involving 60 adults with mild AD, this technology demonstrated solid efficacy: after 7 days of use, stratum corneum hydration increased by 51.07%, TEWL decreased by 13.87%, and the itching VAS score dropped by 20.94%; after 28 days, hydration increased by 78.04%, TEWL decreased by 24.12%, and the EASI score dropped by 26.05%, all with non-irritation and zero adverse events.

From raw material R&D to cosmetics research, efficacy evaluation, and intelligent manufacturing, Laibo Cosmeceuticals has built an end-to-end innovation platform backed by more than 20 years of experience in functional skincare. This trip to Paris was not merely a showcase of Chinese technology going global, but also a global articulation of the skincare philosophy: "empowering the skin to heal itself."

On October 15 at the Louvre in Paris, Laibo Cosmeceuticals presented a tribute to the world—original Chinese technology is opening a gateway to regeneration for sensitive and damaged skin.